OTC : BNIGF

Beroni Group Limited

$0.0064 USD

$0 (0.0%)

Volume
27
Average Volume
24
Market Capitalization
$212.76K
P/E Ratio
-0.06
Dividend Yield
0.00%
Price Target
Year High
$0.01
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.25
Company Overview

OTC

Boqing Zhang

Conglomerates

Healthcare

BNIGF

5

AU

USD

https://www.beronigroup.com

61 2 9283 4808

Q1R81V104

0001851651

Liquidity Metrics

0.36

1.25

1.24

0.35

0.00

Sales & Valuation

$638.3K

0.48

0.06

-0.13

-0.07

Profitability

-$0.13

-$4.22M

-661.66%

-698.77%

-76.18%

-53.25%

P/E Metrics

-0.06

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Poll Results

About Beroni Group Limited (OTC:BNIGF) Stock

Beroni Group Limited, established in 2014 and based in Sydney, Australia, is a global enterprise operating in China, Australia, the United States, and Japan. The company specializes in the creation and distribution of a diverse portfolio of health and wellness products. Its offerings span several key areas: Smoking Harm Reduction: This includes products like NicoBloc, designed to aid in smoking cessation. Environmental Quality: Beroni provides air purification systems, such as Fogibloc, and water filtration solutions under the Olansi brand. Health and Wellness: The company supplies a variety of health supplements and also markets cosmetic products, including V show rejuvenation liquids and various hyaluronic acid and avocado-based intensive treatment masks. Stem cell-derived cosmetic produ ... cts are also part of its range. Diagnostic Tools: Beroni is active in the diagnostics field, offering detection kits for viruses like the SARS-CoV-2 IgG/IgM antibody kit for COVID-19, as well as the CII-ArboViroPlex rRT-PCR assay, which identifies arboviruses such as Zika, Dengue, Chikungunya, and West Nile. Beyond product sales, Beroni Group is heavily invested in research and development. Its R&D efforts focus on discovering and developing novel pharmaceutical drugs, conducting clinical trials, and advancing anti-cancer therapies. The company also provides services in gene detection and diagnosis, infectious disease diagnostics, and offers cell therapies for both cancer treatment and anti-aging applications. Furthermore, Beroni manages an e-commerce platform dedicated to pharmaceutical and healthcare products.

Frequently Asked Questions

What is the current Beroni Group Limited (BNIGF) stock price?

Beroni Group Limited(OTC:BNIGF) stock price is $0.0064 in the last trading session. During the trading session, BNIGF stock reached the peak price of $0.0064 while $0.0021 was the lowest point it dropped to. The percentage change in BNIGF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BNIGF stock was $0.

BNIGF's industry and sector of operation?

The OTC listed BNIGF is part of Conglomerates industry that operates in the broader Healthcare sector.

Who are the executives of BNIGF?

Chen Chik Ong ACIS ACSA FCIS | Non-Executive Director & Company Secretary
Yap Ting Wong | Chief Financial Officer & Executive Director
Boqing Zhang | Founder, Executive Chairman, MD & Chief Executive Officer
Hai Huang | Group Chief Operating Officer, Founder & Executive Director
|

How many employees does BNIGF have?

Number of BNIGF employees currently stands at 5. BNIGF operates from Level 36, Gateway, Sydney, NSW 2000, AU.

Link for BNIGF official website?

Official Website of BNIGF is: https://www.beronigroup.com

How do I contact BNIGF?

BNIGF could be contacted at phone #61 2 9283 4808 and can also be accessed through its website. BNIGF operates from Level 36, Gateway, Sydney, NSW 2000, AU.

How many shares of BNIGF are traded daily?

The average number of BNIGF shares traded daily for last 3 months was 24.

What is the market cap of BNIGF currently?

The market value of BNIGF currently stands at $212.76K with its latest stock price at $0.0064